Pharma Parenteral Packaging Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Pharma Parenteral Packaging Market – By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules, Vials, Prefilled syringes, Cartridges, & Others), By Material (Glass, Polymer, PVC, Others), By Packaging Type (Small Volume Parenteral, Large Volume Parenteral) Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Pharma Parenteral Packaging Market is valued at US$ 13.28 Bn in 2023, and it is expected to reach US$ 18.85 Bn by 2031, with a CAGR of 4.47% during the forecast period of 2024-2031.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2446

Pharma parenteral packaging is created to hold and transport sterile pharmaceutical goods administered through injections. These packaging techniques keep medical products safe, contamination-free, and undamaged in storage, and transit and maintain their potency.

The growing pharmaceutical sector, increasing prevalence of chronic diseases, technological advancements, demand for parenteral packaging and sterile packaging solutions, and increased pharmaceutical expenditure worldwide are driving the pharmaceutical packaging market.

However, with stringent government regulations and standards, the high cost of raw materials used in pharma parenteral packaging, such as glass and plastic, can fluctuate significantly and hamper the market’s growth.

List of Prominent Players in the Pharma Parenteral Packaging Market:

• Adelphi Healthcare Packaging
• Akorn, Inc.
• Alcami Corporation, Inc.
• Amcor
• Ardena Holding NV
• Baxter International Inc.
• Becton, Dickinson and Company
• Berkshire Sterile Manufacturing
• Berry Global Inc.
• Catalent Inc.
• Gerresheimer AG
• Nipro Corporation
• PCI Pharma Services
• Schott AG
• Schur Flexibles Group
• SGD Pharma
• SiO2 Materials Science.
• Stevanato Group S.p.A
• Terumo Corporation
• UDG Healthcare Plc.
• West Pharmaceutical Services, Inc.
• Ypsomed Holding AG

Pharma Parenteral Packaging Market Report Scope:

Market Dynamics:

Drivers-

The growing demand for pharma parenteral packaging market is primarily fueled by the increasing popularity and penetration of generic medications coupled with blockbusters and other small-molecule drugs going off-patent globally. Packaging is crucial for safely storing and transporting medicines. Thus, pharma parenteral packaging utilization will be propelled by the increasing need for generic pharmaceuticals.

Challenges:

Stringent government regulations and standards can potentially slow innovation and increase manufacturers’ costs. Pharma parenteral packaging manufacturers must comply with regulations set by agencies like the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) regarding material compatibility, sterility, and labelling.

Regional Trends:

The North American pharma parenteral packaging market is anticipated to register a significant market share in revenue. It is projected to grow at a high CAGR in the near future because of the presence of major market players, the growing pharmaceutical industry, and more demand for injectable medicine packaging. Besides, Europe had a substantial market share because of expanded vaccine programs and the number of people suffering from chronic and infectious diseases.

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2446

Recent Developments:

• In January 2024, SCHOTT Pharma expanded its global manufacturing network and invested a double-digit million euros in a new production site for pharma drug containment solutions and delivery systems in Jagodina in central Serbia.
• In Nov 2023, Amcor announced the introduction of the newest generation of its Medical Laminates products. Amcor’s newest discovery makes it possible to create recyclable all-film packaging in the polyethylene stream. A mono-material polyethylene (PE) laminate is the latest packaging solution; it can be utilized for catheters, injection and tubing systems, curtains, and protective coverings.
• In October 2023, Gerresheimer launched COP (Cyclic Olefin Polymer) to fill and store sensitive biopharmaceutical mRNA active ingredients.
• In Nov 2022, BD developed the Effivax glass prefillable syringe to enhance biopharmaceutical manufacturing processes by running smoothly on fill/finish packaging lines. The fill/finish and container reliability of Effivax’s design improvements are intended to assist the company’s biopharmaceutical clients in meeting the exacting requirements of vaccine manufacture. The syringe lowers the possibility of a line halt, raises manufacturing capacity, and lowers the total cost of ownership.

Segmentation of Pharma Parenteral Packaging Market-

By Drug Type-

• Small Molecules
• Biologics
• Vaccines
• Biosimilars
• Others

By Product Type-

• Bottles
• Ampoules
• Vials
• Prefilled syringes
• Cartridges
• Others

By Material-

• Glass
• Polymer
• PVC
• Others

By Packaging Type

• Small Volume Parenteral
• Large Volume Parenteral

By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

 Middle East & Africa-

• GCC Countries
• South Africa
• Rest of the Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2446

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/